Silexion Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$2.57

-0.18 (-6.55%)

As of Jun 29, 10:45 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +1,310.1% upside

Low Target $26.81

Average Target $36.24

High Target $52.45

Current Price $2.57

Current
$2.57

Target
$36.24

$26.81 $36.24 avg $52.45

Scenario Analysis

Bear Case

$26.81

943.2%

Low target

Base Case

$36.24

+1,310.1%

Avg target

Bull Case

$52.45

+1,940.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$223.60

-98.9% from high

52-Week Low

$2.31

+11.3% from low

Target vs 52W High

$36.24

-83.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%